Trending Now
Soligenix Inc. (NASDAQ: SNGX) Granted Orphan Drug Designation For Hepricin Ingredient...
Soligenix Inc. (NASDAQ: SNGX) has announced that the US FDA has issued its drug candidate hypericin an Orphan Drug Designation for treatment of T-cell...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Precigen Inc (NASDAQ: PGEN) Announces Definitive Agreement For The Sale Of...
Precigen Inc (NASDAQ: PGEN) has announced a definitive agreement to sell its wholly-owned animal reproductive technology subsidiary Trans Ova Genetics L.C. to URUS for...
MAKE IT MODERN
LATEST REVIEWS
Context Therapeutics Inc. (NASDAQ: CNTX) Releases Onapristone Extended Release (ONA-XR) Study...
Context Therapeutics Inc. (NASDAQ: CNTX) has released data from the window of opportunity clinical study of onapristone extended-release (ONA-XR) in postmenopausal women with progesterone...
MAKE IT MODERN
PERFORMANCE TRAINING
Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine In Adolescents in...
Moderna (NASDAQ: MRNA) has received approval from the Philippines Food and Drug Administration for its coronavirus vaccine for children between 12 and 17 years.
The...
Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For AT-GTX-501 In CLN6...
Amicus Therapeutics (NASDAQ:FOLD) has announced that it has received Priority Medicines designation (PRIME) from the European Medical Agency for its investigational gene therapy, AT-GTX-501,...
Vericel Corporation Inc. (NASDAQ:VCEL) Posts Net Revenue Of $32.3 Million In Q3 2020
Vericel Corporation Inc. (NASDAQ:VCEL) has announced its Q3 2020 financial results posting net revenue of $32.3 million and also provided business updates.
Vericel reports total...
Affimed NV (NASDAQ:AFMD) And NKMax America Sign Collaborative Deal To Study A AFM24 and...
Affimed NV (NASDAQ:AFMD) recently announced that it signed a collaborative agreement with NKMax America Inc., through which they will both investigate a combination therapy...
Celsion Corporation (NASDAQ:CLSN) Presents A Poster Highlighting Its Phase I And II OVATION 2...
Celsion Corporation (NASDAQ:CLSN) presented a poster at a Virtual Annual Meeting on Women’s cancer showing the progress of its Phase I and II Ovation...
MAKE IT MODERN
